| scholarly article | Q13442814 |
| P50 | author | Luigi Ferrucci | Q28050062 |
| Michelle M Mielke | Q60909929 | ||
| Constantine G. Lyketsos | Q91213781 | ||
| Susan Resnick | Q96091890 | ||
| P2093 | author name string | Norman J Haughey | |
| Veera Venkata Ratnam Bandaru | |||
| Yang An | |||
| Dingfen Han | |||
| P2860 | cites work | Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics | Q21560953 |
| Discovery of sexual dimorphisms in metabolic and genetic biomarkers | Q21563382 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Plasma and serum lipidomics of healthy white adults shows characteristic profiles by subjects' gender and age | Q28397688 | ||
| Ceramides and cardiac function in children with chronic kidney disease. | Q33797077 | ||
| Blood sphingolipidomics in healthy humans: impact of sample collection methodology | Q34116310 | ||
| Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease | Q34223125 | ||
| Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline | Q34284146 | ||
| Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A. | Q34317415 | ||
| Sphingolipid metabolism regulates development and lifespan in Caenorhabditis elegans | Q34938909 | ||
| Factors affecting longitudinal trajectories of plasma sphingomyelins: the Baltimore Longitudinal Study of Aging | Q35027653 | ||
| Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets? | Q35086073 | ||
| Raft ceramide in molecular medicine | Q35559152 | ||
| Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer's disease | Q35566575 | ||
| Associative and predictive biomarkers of dementia in HIV-1-infected patients | Q35606267 | ||
| Goodpasture antigen-binding protein/ceramide transporter binds to human serum amyloid P-component and is present in brain amyloid plaques | Q35922569 | ||
| Gender modulates the APOE ε4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels | Q36089835 | ||
| Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. | Q36149981 | ||
| Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway | Q36321788 | ||
| Demographic and clinical variables affecting mid- to late-life trajectories of plasma ceramide and dihydroceramide species | Q36409995 | ||
| Sphingomyelin SM(d18:1/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid-β42, tau, and phospho-tau-181 levels | Q36424510 | ||
| Human serum metabolic profiles are age dependent | Q36498753 | ||
| Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance | Q36560514 | ||
| Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease | Q36604677 | ||
| Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease? | Q36768801 | ||
| Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism | Q36861002 | ||
| Lipid mediators of insulin resistance | Q36867145 | ||
| Lipidomics of familial longevity | Q37005030 | ||
| Plasma sphingolipids and lung cancer: a population-based, nested case-control study | Q37069137 | ||
| Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study | Q37091714 | ||
| Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling | Q37123974 | ||
| Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase | Q37378380 | ||
| ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain | Q37379675 | ||
| Serum sphingomyelins and ceramides are early predictors of memory impairment | Q37437931 | ||
| A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects | Q37463446 | ||
| Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences. | Q37477478 | ||
| Sphingolipids and lifespan regulation | Q37586487 | ||
| The ceramide transporter and the Goodpasture antigen binding protein: one protein--one function? | Q37710735 | ||
| Ceramide function in the brain: when a slight tilt is enough. | Q38021345 | ||
| Active gamma-secretase is localized to detergent-resistant membranes in human brain | Q40014328 | ||
| A failure to normalize biochemical and metabolic insults during morphine withdrawal disrupts synaptic repair in mice transgenic for HIV-gp120. | Q42282888 | ||
| Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid | Q42474499 | ||
| Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis | Q44370232 | ||
| Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study | Q44697763 | ||
| Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia | Q44750872 | ||
| Association of ceramides in human plasma with risk factors of atherosclerosis | Q44772533 | ||
| Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin | Q46755710 | ||
| Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment | Q46819942 | ||
| The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism | Q47216511 | ||
| Ceramide activates heterotrimeric protein phosphatase 2A. | Q48246807 | ||
| Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease | Q48557430 | ||
| Complement activation by ceramide transporter proteins. | Q50667189 | ||
| TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E. | Q54796030 | ||
| Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI | Q68789670 | ||
| Protein Phosphatase 2A Is the Major Enzyme in Brain that Dephosphorylates τ Protein Phosphorylated by Proline‐Directed Protein Kinases or Cyclic AMP‐Dependent Protein Kinase | Q71832645 | ||
| Nano-HPLC-MS analysis of phospholipids in cerebrospinal fluid of Alzheimer's disease patients--a pilot study | Q85209683 | ||
| P433 | issue | 3 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| ceramides | Q424213 | ||
| P304 | page(s) | 819-828 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
| P1476 | title | The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging | |
| P478 | volume | 60 |
| Q64249316 | A Data Science-Based Analysis Points at Distinct Patterns of Lipid Mediator Plasma Concentrations in Patients With Dementia |
| Q92082191 | Alteration of Sphingolipids in Biofluids: Implications for Neurodegenerative Diseases |
| Q92721755 | Circulating ceramide ratios and risk of vascular brain aging and dementia |
| Q90146269 | Cold-induced lipid dynamics and transcriptional programs in white adipose tissue |
| Q58803874 | Evaluation of serum sphingolipids and the influence of genetic risk factors in age-related macular degeneration |
| Q90598631 | Extracorporeal apheresis therapy for Alzheimer disease-targeting lipids, stress, and inflammation |
| Q90837622 | Lipidomic characterization of extracellular vesicles in human serum |
| Q64107339 | Longitudinal plasma metabolomics of aging and sex |
| Q64072375 | Plasma lipidome variation during the second half of the human lifespan is associated with age and sex but minimally with BMI |
| Q89983254 | Sex and APOE ε4 genotype modify the Alzheimer's disease serum metabolome |
| Q90643094 | Sphingolipid metabolism in type 2 diabetes and associated cardiovascular complications |
| Q47619466 | Sphingolipids in Alzheimer's Disease and Related Disorders |
Search more.